EP1021462A4 - Essais pour ligands a recepteurs nucleaires reposant sur le transfert d'energie de resonance en fluorescence - Google Patents

Essais pour ligands a recepteurs nucleaires reposant sur le transfert d'energie de resonance en fluorescence

Info

Publication number
EP1021462A4
EP1021462A4 EP98956094A EP98956094A EP1021462A4 EP 1021462 A4 EP1021462 A4 EP 1021462A4 EP 98956094 A EP98956094 A EP 98956094A EP 98956094 A EP98956094 A EP 98956094A EP 1021462 A4 EP1021462 A4 EP 1021462A4
Authority
EP
European Patent Office
Prior art keywords
fret
assays
nuclear receptor
receptor ligands
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98956094A
Other languages
German (de)
English (en)
Other versions
EP1021462A1 (fr
Inventor
Richard T Cummings
Jeffrey D Hermes
David E Moller
Gaochao Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1021462A1 publication Critical patent/EP1021462A1/fr
Publication of EP1021462A4 publication Critical patent/EP1021462A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
EP98956094A 1997-10-07 1998-10-06 Essais pour ligands a recepteurs nucleaires reposant sur le transfert d'energie de resonance en fluorescence Withdrawn EP1021462A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6138597P 1997-10-07 1997-10-07
US61385P 1997-10-07
PCT/US1998/021049 WO1999018124A1 (fr) 1997-10-07 1998-10-06 Essais pour ligands a recepteurs nucleaires reposant sur le transfert d'energie de resonance en fluorescence

Publications (2)

Publication Number Publication Date
EP1021462A1 EP1021462A1 (fr) 2000-07-26
EP1021462A4 true EP1021462A4 (fr) 2005-04-13

Family

ID=22035450

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98956094A Withdrawn EP1021462A4 (fr) 1997-10-07 1998-10-06 Essais pour ligands a recepteurs nucleaires reposant sur le transfert d'energie de resonance en fluorescence

Country Status (4)

Country Link
EP (1) EP1021462A4 (fr)
JP (1) JP2001519525A (fr)
CA (1) CA2305711A1 (fr)
WO (1) WO1999018124A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002528721A (ja) * 1998-10-23 2002-09-03 グラクソ グループ リミテッド 核内受容体のリガンド用のアッセイ
EP1140079B1 (fr) * 1998-12-23 2009-06-03 Glaxo Group Limited Methodes de titrage de ligands de recepteurs nucleaires
WO2001020326A2 (fr) * 1999-09-13 2001-03-22 Equitech Laboratories, Inc. Materiaux et procede de detection et de quantification d'un analysat
WO2001040805A1 (fr) * 1999-11-30 2001-06-07 Akzo Nobel N.V. Composes steroidiques destines a des dosages par liaison de recepteur de steroides
WO2001071352A2 (fr) * 2000-03-17 2001-09-27 The Salk Institute For Biological Studies Compositions associees a la formation de complexes et leurs procedes d'utilisation
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6924311B2 (en) 2001-10-17 2005-08-02 X-Ceptor Therapeutics, Inc. Methods for affecting various diseases utilizing LXR compounds
DE60116109T2 (de) 2001-11-07 2006-09-07 Schering Ag In vitro Screening nach Liganden des Östrogenrezeptors
WO2004010107A2 (fr) * 2002-07-24 2004-01-29 3-Dimensional Pharmaceuticals, Inc. Procede permettant de determiner la regulation de l'elimination des xenobiotiques
WO2004042404A1 (fr) * 2002-11-07 2004-05-21 Erasmus Universiteit Rotterdam Sondes fret et procedes de detection de molecules d'interaction
JP4803976B2 (ja) * 2003-07-09 2011-10-26 独立行政法人科学技術振興機構 細胞内ｉｐ３測定用分子センサー
WO2005021025A2 (fr) * 2003-08-28 2005-03-10 Choongwae Pharma Corporation Modulation de la transcription activee par ?-catenine/tcf
WO2005054438A2 (fr) 2003-12-01 2005-06-16 Invitrogen Corporation Molecule d'acide nucleique contenant des sites de recombinaison et leurs procedes d'utilisation
US20080286260A1 (en) * 2004-03-26 2008-11-20 Bayer Healthcare Ag Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara)
KR100704011B1 (ko) 2005-02-16 2007-04-04 한국과학기술원 금속나노입자와 양자점의 ｆｒｅｔ에 의한 생체분자특이결합 검출 방법
JP4936476B2 (ja) * 2005-06-28 2012-05-23 第一三共株式会社 Ｌｘｒリガンドの試験方法
JP5264421B2 (ja) 2007-11-22 2013-08-14 富士フイルム株式会社 被験物測定用担体およびその製造方法
WO2009141926A1 (fr) * 2008-05-23 2009-11-26 国立大学法人東京大学 Procédé d'acquisition d'un composé capable d'agir sur le métabolisme du glucose/métabolisme lipidique
WO2015159292A2 (fr) 2014-04-14 2015-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé et kit permettant de déterminer l'origine tissulaire ou cellulaire de l'adn
JP2019521673A (ja) 2016-06-07 2019-08-08 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 疾患および状態の分析のためのセルフリーｄｎａメチル化パターン

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056806A1 (fr) * 1997-06-12 1998-12-17 The Regents Of The University Of California Proteine de coactivation de facteur de transcription, p/cip
WO1999041608A2 (fr) * 1998-02-12 1999-08-19 Prolifix Limited Interaction de la cycline d1 et des coactivateurs de recepteur steroidien, et utilisations aux fins d'essais

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608143D0 (en) * 1996-04-19 1996-06-26 Ver Nl Kanker Inst Assay

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056806A1 (fr) * 1997-06-12 1998-12-17 The Regents Of The University Of California Proteine de coactivation de facteur de transcription, p/cip
WO1999041608A2 (fr) * 1998-02-12 1999-08-19 Prolifix Limited Interaction de la cycline d1 et des coactivateurs de recepteur steroidien, et utilisations aux fins d'essais

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
CLINICAL CHEMISTRY, vol. 43, no. 6 PART 2, 1997, 49TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY; ATLANTA, GEORGIA, USA; JULY 20-24, 1997, pages S159, ISSN: 0009-9147 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 22 July 1997 (1997-07-22), BELLANGER L ET AL: "Homogeneous time-resolved fluoroimmunoassay for cardiac troponin-I using TRACE technology", XP008042758, Database accession no. PREV199799633726 *
KOLB A J ET AL: "HOMOGENEOUS, TIME-RESOLVED FLUORESCENCE METHOD FOR DRUG DISCOVERY", 1997, HIGH-THROUGHPUT SCREENING, THE DISCOVERY OF BIOACTIVE SUBSTANCES, XX, XX, PAGE(S) 345-360, XP008042717 *
KOLB J M ET AL: "USE OF A NOVEL HOMOGENEOUS FLUORESCENT TECHNOLOGY IN HIGH THROUGHPUT SCREENING", JOURNAL OF BIOMOLECULAR SCREENING, LARCHMONT, NY, US, vol. 1, no. 4, 1996, pages 203 - 210, XP008042702, ISSN: 1087-0571 *
LEE S P ET AL: "CHARACTERIZATION OF ENDONUCLEOLYTIC ACTIVITY OF HIV-1 INTEGRASE USING A FLUOROGENIC SUBSTRATE", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 227, 1995, pages 295 - 301, XP002945389, ISSN: 0003-2697 *
MATHIS G: "PROBING MOLECULAR INTERACTIONS WITH HOMOGENEOUS TECHNIQUES BASED ONRARE EARTH CRYPTATES AND FLUORESCENCE ENERGY TRANSFER", CLINICAL CHEMISTRY, vol. 41, no. 9, 1995, pages 1391 - 1397, XP001018128, ISSN: 0009-9147 *
ROGERS M V: "LIGHT ON HIGH-THROUGHPUT SCREENING: FLUORESCENCE-BASED ASSAY TECHNOLOGIES", DRUG DISCOVERY TODAY, ELSEVIER SCIENCE LTD, GB, vol. 2, no. 4, April 1997 (1997-04-01), pages 156 - 160, XP002916138, ISSN: 1359-6446 *
See also references of WO9918124A1 *
ZHOU G ET AL: "Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation", METHODS : A COMPANION TO METHODS IN ENZYMOLOGY, ACADEMIC PRESS INC., NEW YORK, NY, US, vol. 25, no. 1, September 2001 (2001-09-01), pages 54 - 61, XP002267175, ISSN: 1046-2023 *

Also Published As

Publication number Publication date
EP1021462A1 (fr) 2000-07-26
JP2001519525A (ja) 2001-10-23
WO1999018124A1 (fr) 1999-04-15
CA2305711A1 (fr) 1999-04-15

Similar Documents

Publication Publication Date Title
EP1021462A4 (fr) Essais pour ligands a recepteurs nucleaires reposant sur le transfert d'energie de resonance en fluorescence
GB2344589B (en) Non-steroidal ligands for the estrogen receptor
HUP0104666A3 (en) Thyroid receptor ligands
EP0890102A4 (fr) Dosages biologiques utilisant des microparticules de reference
EP1137940A4 (fr) Procede d'identification de ligands de recepteurs nucleaires
HUP0101719A3 (en) Improved immunodiagnostic assays using reducing agents
EP1066320A4 (fr) Recepteur nucleaire orphelin
GB9815702D0 (en) Improved imaging system for fluorescence assays
EP0873142A4 (fr) Epreuves de selection de composes
GB2315130B (en) Improved imaging system for fluorescence assays
EP1008042A4 (fr) Architecture de tolerance de fautes pour programmation en-circuit
GB9715522D0 (en) Assays
EP0973800A4 (fr) Nouveau recepteur
GB2328960B (en) Washout arrangement for a well
GB9917009D0 (en) Improved imaging system for fluoresennce assays
HUP9901579A3 (en) Antibodies specific for alpha-d-integrin
GB9718911D0 (en) Monoclonal antibodies
DE29707061U1 (de) Adventskalender zum Befüllen
GB9803062D0 (en) Estrogen receptor ligands
HUP0002758A3 (en) Non-steroidal ligands for the estrogen receptor
GB9711992D0 (en) Estrogen receptor ligands
GB9717346D0 (en) Estrogen receptor ligands
GB9812146D0 (en) Assays for TSH receptor autoantibodies
GB9722884D0 (en) Estrogen receptor
TW383765U (en) Binding & fixing seat for template washer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000508

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20050225

17Q First examination report despatched

Effective date: 20060915

17Q First examination report despatched

Effective date: 20060915

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071204